Shi, TingPan, JiafengVasileiou, EleftheriaRobertson, ChrisSheikh, AzizPublic Health Scotland and the EAVE II Collaborators2022-04-072022-04-072022-04Shi, T, Pan, J, Vasileiou, E, Robertson, C, Sheikh, A & Public Health Scotland and the EAVE II Collaborators 2022, 'Risk of serious COVID-19 outcomes among adults with asthma in Scotland : a national incident cohort study', The Lancet. Respiratory medicine, vol. 10, no. 4, pp. 347-354. https://doi.org/10.1016/S2213-2600(21)00543-92213-2600PubMedCentral: PMC8758152https://hdl.handle.net/2164/18363We thank the EAVE II Patient Advisory Group for their support. EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE—The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. This research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant reference MC_PC_20058). Additional support has been provided through Public Health Scotland and Scottish Government DG Health and Social Care and the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation.8612357engSDG 3 - Good Health and Well-beingSDG 9 - Industry, Innovation, and InfrastructureAdolescentAdultAsthma/drug therapyCOVID-19/epidemiologyCOVID-19 VaccinesCohort StudiesHospitalizationHumansSARS-CoV-2Scotland/epidemiologyR MedicineMedical Research Council (MRC)MR/R008345/1RJournal article10.1016/S2213-2600(21)00543-9104